» Articles » PMID: 30524644

Impact of a Digital Health Intervention on Asthma Resource Utilization

Overview
Date 2018 Dec 8
PMID 30524644
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Digital health interventions have been associated with reduced rescue inhaler use and improved controller medication adherence. This quality improvement project assessed the benefit of these interventions on asthma-related healthcare utilizations, including hospitalizations, emergency department (ED) utilization and outpatient visits. The intervention consisted of electronic medication monitors (EMMs) that tracked rescue and controller inhaler medication use, and a digital health platform that presented medication use information and asthma control status to patients and providers. In 224 study patients, the number of asthma-related ED visits and combined ED and hospitalization events 365 days pre- to 365 days post-enrollment to the intervention significantly decreased from 11.6 to 5.4 visits ( < 0.05) and 13.4 to 5.8 events ( < 0.05) per 100 patient-years, respectively. This digital health intervention was successfully incorporated into routine clinical practice and was associated with lower rates of asthma-related hospitalizations and ED visits.

Citing Articles

Evaluating digital adherence support in asthma: the ADITION non-interventional study.

Woehrle H, Driemert J, Jerrentrup L, Schiefer C, Bushart G, Schwab Sauerbeck I ERJ Open Res. 2025; 11(2).

PMID: 40040901 PMC: 11874225. DOI: 10.1183/23120541.00734-2024.


Evaluation of a Primary Care-Integrated Mobile Health Intervention to Monitor between-Visit Asthma Symptoms.

Sulca Flores J, Dalal A, Sousa J, Foer D, Rodriguez J, Plombon S Appl Clin Inform. 2024; 15(4):785-797.

PMID: 39357877 PMC: 11446627. DOI: 10.1055/s-0044-1788978.


Impact of digital infrastructure construction on the migrants' utilization of basic public health services in China.

Jia H BMC Health Serv Res. 2024; 24(1):761.

PMID: 38910262 PMC: 11194986. DOI: 10.1186/s12913-024-11221-7.


Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing.

Miao B, Sushil M, Xu A, Wang M, Arneson D, Berkley E Lancet Digit Health. 2024; 6(3):e222-e229.

PMID: 38395542 PMC: 11074920. DOI: 10.1016/S2589-7500(23)00244-3.


Prediction of short-acting beta-agonist usage in patients with asthma using temporal-convolutional neural networks.

Hirons N, Allen A, Matsuyoshi N, Su J, Kaye L, Barrett M JAMIA Open. 2023; 6(4):ooad091.

PMID: 37900973 PMC: 10602590. DOI: 10.1093/jamiaopen/ooad091.


References
1.
Barrett M, Humblet O, Marcus J, Henderson K, Smith T, Eid N . Effect of a mobile health, sensor-driven asthma management platform on asthma control. Ann Allergy Asthma Immunol. 2017; 119(5):415-421.e1. DOI: 10.1016/j.anai.2017.08.002. View

2.
Delea T, Stanford R, Hagiwara M, Stempel D . Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*. Curr Med Res Opin. 2008; 24(12):3435-42. DOI: 10.1185/03007990802557344. View

3.
Pelaez S, Lamontagne A, Collin J, Gauthier A, Grad R, Blais L . Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy. BMC Pulm Med. 2015; 15:42. PMC: 4429418. DOI: 10.1186/s12890-015-0044-9. View

4.
Murphy A, Proeschal A, Brightling C, Wardlaw A, Pavord I, Bradding P . The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax. 2012; 67(8):751-3. DOI: 10.1136/thoraxjnl-2011-201096. View

5.
Merchant R, Inamdar R, Quade R . Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2016; 4(3):455-63. DOI: 10.1016/j.jaip.2015.11.022. View